Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
Two Stanford University experts made their case for using molecular imaging to select patients for 177-Lu-PSMA-617 in a new Journal of Nuclear Medicine editorial.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
